William J. Kerns, MD

Which medications benefit patients with diastolic heart failure?

Author:: Micah Crouse, MD; David Flack, DO; William J. Kerns, MD; Larisa Martin, MD; Daniel Pham, MD; Ramashilpa Sudireddy, MD; Karen Knight, MSLS

EVIDENCE-BASED ANSWER: Aangiotensin-converting enzyme inhibitors (ACEIs), propranolol, statins, furosemide, and some angiotensin receptor blockers...

Author:: Chaitanya Alli, MD; Monina Daguio, MD; Marin Kosciuk, MD; Charles Middelhoff, MD; Kimberley Wyrick, DO; William J. Kerns, MD; Karen Knight, MSLS

EVIDENCE-BASED ANSWER: Yes. Patients with type 2 diabetes benefit from case management, as evidenced by decreased glycated hemoglobin (HbA1c). The...

EVIDENCE-BASED ANSWER: Tricyclic antidepressants and intensive multi-disciplinary programs are moderately effective for reducing chronic back pain...

Author:: Alex Akhavan, MD; Cynthia Flores, DO; Shannan Green, MD; Jason Hackett, MD; Minh Nguyen, MD; William J. Kerns, MD; Karen Knight, MSLS

EVIDENCE-BASED ANSWER: Athletes sustaining a concussion should be held from contact activities a minimum of 7 days; they must be asymptomatic and...

Author:: Gina Adair, MD; Joel Grant, MD; Nancy Pandhi, MD; Robert Saunders, MD; Iris Sadowsky, DO; Brian West, MD; William J. Kerns, MD; Karen Knight, MSLS

EVIDENCE-BASED ANSWER: Thrombolytic therapy should be limited to patients with acute ischemic stroke who meet strict inclusion and exclusion...

EVIDENCE-BASED ANSWER: Beta-blockers (class II antiarrhythmics) reduce sudden death and total mortality in patients with heart failure (strength...